EZH2 has been implicated in PCa development and progression,11, 12, 13, 14, 15, 16, 17, 18, 19, 20 but to date, this knowledge has not yielded clinical benefit for patients. This evidence concerns the gene EZH2 and posterior cortical atrophy.